Cargando…
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observationa...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934910/ https://www.ncbi.nlm.nih.gov/pubmed/35313890 http://dx.doi.org/10.1186/s12931-022-01994-y |
_version_ | 1784671930609041408 |
---|---|
author | Faverio, Paola Luppi, Fabrizio Rebora, Paola D’Andrea, Gabriele Stainer, Anna Busnelli, Sara Catalano, Martina Modafferi, Giuseppe Franco, Giovanni Monzani, Anna Galimberti, Stefania Scarpazza, Paolo Oggionni, Elisa Betti, Monia Oggionni, Tiberio De Giacomi, Federica Bini, Francesco Bodini, Bruno Dino Parati, Mara Bilucaglia, Luca Ceruti, Paolo Modina, Denise Harari, Sergio Caminati, Antonella Intotero, Marcello Sergio, Pietro Monzillo, Giuseppe Leati, Giovanni Borghesi, Andrea Zompatori, Maurizio Corso, Rocco Valsecchi, Maria Grazia Bellani, Giacomo Foti, Giuseppe Pesci, Alberto |
author_facet | Faverio, Paola Luppi, Fabrizio Rebora, Paola D’Andrea, Gabriele Stainer, Anna Busnelli, Sara Catalano, Martina Modafferi, Giuseppe Franco, Giovanni Monzani, Anna Galimberti, Stefania Scarpazza, Paolo Oggionni, Elisa Betti, Monia Oggionni, Tiberio De Giacomi, Federica Bini, Francesco Bodini, Bruno Dino Parati, Mara Bilucaglia, Luca Ceruti, Paolo Modina, Denise Harari, Sergio Caminati, Antonella Intotero, Marcello Sergio, Pietro Monzillo, Giuseppe Leati, Giovanni Borghesi, Andrea Zompatori, Maurizio Corso, Rocco Valsecchi, Maria Grazia Bellani, Giacomo Foti, Giuseppe Pesci, Alberto |
author_sort | Faverio, Paola |
collection | PubMed |
description | BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observational study, patients hospitalised for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support (“oxygen only”, “continuous positive airway pressure (CPAP)” and “invasive mechanical ventilation (IMV)”) and followed up at 12 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6 min walking test, high resolution CT (HRCT) scan, and modified Medical Research Council (mMRC) dyspnea scale were collected. RESULTS: Out of 287 patients hospitalized with SARS-CoV-2 pneumonia and followed up at 1 year, DLCO impairment, mainly of mild entity and improved with respect to the 6-month follow-up, was observed more frequently in the “oxygen only” and “IMV” group (53% and 49% of patients, respectively), compared to 29% in the “CPAP” group. Abnormalities at chest HRCT were found in 46%, 65% and 80% of cases in the “oxygen only”, “CPAP” and “IMV” group, respectively. Non-fibrotic interstitial lung abnormalities, in particular reticulations and ground-glass attenuation, were the main finding, while honeycombing was found only in 1% of cases. Older patients and those requiring IMV were at higher risk of developing radiological pulmonary sequelae. Dyspnea evaluated through mMRC scale was reported by 35% of patients with no differences between groups, compared to 29% at 6-month follow-up. CONCLUSION: DLCO alteration and non-fibrotic interstitial lung abnormalities are common after 1 year from hospitalization due to SARS-CoV-2 pneumonia, particularly in older patients requiring higher ventilatory support. Studies with longer follow-ups are needed. |
format | Online Article Text |
id | pubmed-8934910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89349102022-03-21 One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study Faverio, Paola Luppi, Fabrizio Rebora, Paola D’Andrea, Gabriele Stainer, Anna Busnelli, Sara Catalano, Martina Modafferi, Giuseppe Franco, Giovanni Monzani, Anna Galimberti, Stefania Scarpazza, Paolo Oggionni, Elisa Betti, Monia Oggionni, Tiberio De Giacomi, Federica Bini, Francesco Bodini, Bruno Dino Parati, Mara Bilucaglia, Luca Ceruti, Paolo Modina, Denise Harari, Sergio Caminati, Antonella Intotero, Marcello Sergio, Pietro Monzillo, Giuseppe Leati, Giovanni Borghesi, Andrea Zompatori, Maurizio Corso, Rocco Valsecchi, Maria Grazia Bellani, Giacomo Foti, Giuseppe Pesci, Alberto Respir Res Research BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observational study, patients hospitalised for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support (“oxygen only”, “continuous positive airway pressure (CPAP)” and “invasive mechanical ventilation (IMV)”) and followed up at 12 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6 min walking test, high resolution CT (HRCT) scan, and modified Medical Research Council (mMRC) dyspnea scale were collected. RESULTS: Out of 287 patients hospitalized with SARS-CoV-2 pneumonia and followed up at 1 year, DLCO impairment, mainly of mild entity and improved with respect to the 6-month follow-up, was observed more frequently in the “oxygen only” and “IMV” group (53% and 49% of patients, respectively), compared to 29% in the “CPAP” group. Abnormalities at chest HRCT were found in 46%, 65% and 80% of cases in the “oxygen only”, “CPAP” and “IMV” group, respectively. Non-fibrotic interstitial lung abnormalities, in particular reticulations and ground-glass attenuation, were the main finding, while honeycombing was found only in 1% of cases. Older patients and those requiring IMV were at higher risk of developing radiological pulmonary sequelae. Dyspnea evaluated through mMRC scale was reported by 35% of patients with no differences between groups, compared to 29% at 6-month follow-up. CONCLUSION: DLCO alteration and non-fibrotic interstitial lung abnormalities are common after 1 year from hospitalization due to SARS-CoV-2 pneumonia, particularly in older patients requiring higher ventilatory support. Studies with longer follow-ups are needed. BioMed Central 2022-03-21 2022 /pmc/articles/PMC8934910/ /pubmed/35313890 http://dx.doi.org/10.1186/s12931-022-01994-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Faverio, Paola Luppi, Fabrizio Rebora, Paola D’Andrea, Gabriele Stainer, Anna Busnelli, Sara Catalano, Martina Modafferi, Giuseppe Franco, Giovanni Monzani, Anna Galimberti, Stefania Scarpazza, Paolo Oggionni, Elisa Betti, Monia Oggionni, Tiberio De Giacomi, Federica Bini, Francesco Bodini, Bruno Dino Parati, Mara Bilucaglia, Luca Ceruti, Paolo Modina, Denise Harari, Sergio Caminati, Antonella Intotero, Marcello Sergio, Pietro Monzillo, Giuseppe Leati, Giovanni Borghesi, Andrea Zompatori, Maurizio Corso, Rocco Valsecchi, Maria Grazia Bellani, Giacomo Foti, Giuseppe Pesci, Alberto One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title | One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title_full | One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title_fullStr | One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title_full_unstemmed | One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title_short | One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study |
title_sort | one-year pulmonary impairment after severe covid-19: a prospective, multicenter follow-up study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934910/ https://www.ncbi.nlm.nih.gov/pubmed/35313890 http://dx.doi.org/10.1186/s12931-022-01994-y |
work_keys_str_mv | AT faveriopaola oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT luppifabrizio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT reborapaola oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT dandreagabriele oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT staineranna oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT busnellisara oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT catalanomartina oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT modafferigiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT francogiovanni oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT monzanianna oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT galimbertistefania oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT scarpazzapaolo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT oggionnielisa oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT bettimonia oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT oggionnitiberio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT degiacomifederica oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT binifrancesco oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT bodinibrunodino oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT paratimara oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT bilucaglialuca oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT cerutipaolo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT modinadenise oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT hararisergio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT caminatiantonella oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT intoteromarcello oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT sergiopietro oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT monzillogiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT leatigiovanni oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT borghesiandrea oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT zompatorimaurizio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT corsorocco oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT valsecchimariagrazia oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT bellanigiacomo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT fotigiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy AT pescialberto oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy |